2022-07-07-世界卫生组织-45th_ECDD_questionnaire_7页_233kb

WHO ECDD 45th Expert Committee Questionnaire Summary

Introduction

• Survey Overview: This questionnaire assesses information on a specific controlled substance for WHO's 45th Expert Committee on Drug Dependence (ECDD), expected to take 15-25 minutes to complete. Respondents can amend answers until closure.
• Data Publication: Responses are compiled into a public report on the WHO ECDD website, attributing country names unless anonymized. Sensitive documents for ECDD Secretariat should be emailed to ecddsecretariat@who.int.

Response Requirements

• Consent to Publication: Respondents must agree to publish data, with an option for country anonymity.
• Data Sharing Policy Agreement: Requires confirmation that data was collected per national laws, including data protection laws. WHO will publish anonymized data for noncommercial public health use while respecting country acknowledgment.

Section 0: Substance Information

• General Info: Covers substance use in medicine, science, industry, and non-medical/recreational contexts.

Section 1: Approved Medical/Sscientific Use

• Availability: Multiple-choice on the availability of human/veterinary medical products.
• Therapeutic Indications: Requires listing the approved medical uses.
• Research Use: Inquiry on current use in clinical research or trials (excluding reference standards).

Section 2: Industrial Use

• Industrial Applications: Yes/No on industrial use, with specification if yes.

Section 3: Epidemiology of Non-Medical Use

• Evidence of Use: Confirmation of non-medical use evidence and possible routes/methods.
• Magnitude of Harm: Quantification of public health/social harm caused.
• Health Impact: Assessment of negative health effects (negligible, substantial, or especially serious).
• Emergency Room Data: Information on emergency room visits and adverse effects.

Section 4: Current Control

• National Legislation: Inquiry on legal control to regulate availability.
• Illicit Activities: Checklist for activities beyond medical/scientific use, such as smuggling, trafficking, etc.
• Seizures: Data on seizures over 2020, 2021, and 2022.
• Laboratory Capacity: Forensic lab capacity to analyze the substance if placed under international control.

Additional Information

• Optional Comments: Space to provide any further information.

Summary of Data Handling

• Submission Format: Use numerals for reporting numbers in deaths and seizures.
• Completion: Final report may publish country names unless specified for anonymity, and WHO controls the publication of shared data.